253 related articles for article (PubMed ID: 12154073)
21. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases.
Miyamori H; Takino T; Kobayashi Y; Tokai H; Itoh Y; Seiki M; Sato H
J Biol Chem; 2001 Jul; 276(30):28204-11. PubMed ID: 11382769
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins.
Hiraoka N; Allen E; Apel IJ; Gyetko MR; Weiss SJ
Cell; 1998 Oct; 95(3):365-77. PubMed ID: 9814707
[TBL] [Abstract][Full Text] [Related]
23. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
[TBL] [Abstract][Full Text] [Related]
24. Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical.
Nisato RE; Hosseini G; Sirrenberg C; Butler GS; Crabbe T; Docherty AJ; Wiesner M; Murphy G; Overall CM; Goodman SL; Pepper MS
Cancer Res; 2005 Oct; 65(20):9377-87. PubMed ID: 16230401
[TBL] [Abstract][Full Text] [Related]
25. Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
Lee MH; Rapti M; Murphy G
J Biol Chem; 2003 Oct; 278(41):40224-30. PubMed ID: 12869573
[TBL] [Abstract][Full Text] [Related]
26. Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation.
Ben-Yosef Y; Lahat N; Shapiro S; Bitterman H; Miller A
Circ Res; 2002 Apr; 90(7):784-91. PubMed ID: 11964371
[TBL] [Abstract][Full Text] [Related]
27. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.
Endo K; Takino T; Miyamori H; Kinsen H; Yoshizaki T; Furukawa M; Sato H
J Biol Chem; 2003 Oct; 278(42):40764-70. PubMed ID: 12904296
[TBL] [Abstract][Full Text] [Related]
28. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
29. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
30. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
31. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.
Théret N; Musso O; L'Helgoualc'h A; Campion JP; Clément B
Am J Pathol; 1998 Sep; 153(3):945-54. PubMed ID: 9736043
[TBL] [Abstract][Full Text] [Related]
32. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells.
Taraboletti G; D'Ascenzo S; Borsotti P; Giavazzi R; Pavan A; Dolo V
Am J Pathol; 2002 Feb; 160(2):673-80. PubMed ID: 11839588
[TBL] [Abstract][Full Text] [Related]
33. Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas.
Van Meter TE; Broaddus WC; Rooprai HK; Pilkington GJ; Fillmore HL
Neuro Oncol; 2004 Jul; 6(3):188-99. PubMed ID: 15279711
[TBL] [Abstract][Full Text] [Related]
34. Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells.
Shofuda KI; Hasenstab D; Kenagy RD; Shofuda T; Li ZY; Lieber A; Clowes AW
FASEB J; 2001 Sep; 15(11):2010-2. PubMed ID: 11511522
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis.
Pohl M; Sakurai H; Bush KT; Nigam SK
Am J Physiol Renal Physiol; 2000 Nov; 279(5):F891-900. PubMed ID: 11053050
[TBL] [Abstract][Full Text] [Related]
36. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.
Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
J Biol Chem; 1998 Dec; 273(52):34745-52. PubMed ID: 9856998
[TBL] [Abstract][Full Text] [Related]
37. Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells.
Taraboletti G; Sonzogni L; Vergani V; Hosseini G; Ceruti R; Ghilardi C; Bastone A; Toschi E; Borsotti P; Scanziani E; Giavazzi R; Pepper MS; Stetler-Stevenson WG; Bani MR
Exp Cell Res; 2000 Aug; 258(2):384-94. PubMed ID: 10896789
[TBL] [Abstract][Full Text] [Related]
38. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury.
Shofuda K; Nagashima Y; Kawahara K; Yasumitsu H; Miki K; Miyazaki K
Lab Invest; 1998 Aug; 78(8):915-23. PubMed ID: 9714179
[TBL] [Abstract][Full Text] [Related]
39. Membrane-type matrix metalloproteinases and vascularization in human endometrium during the menstrual cycle.
Plaisier M; Koolwijk P; Hanemaaijer R; Verwey RA; van der Weiden RM; Risse EK; Jungerius C; Helmerhorst FM; van Hinsbergh VW
Mol Hum Reprod; 2006 Jan; 12(1):11-8. PubMed ID: 16415334
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte growth factor enhances MMP activity in human endothelial cells.
Wang H; Keiser JA
Biochem Biophys Res Commun; 2000 Jun; 272(3):900-5. PubMed ID: 10860849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
